214 related articles for article (PubMed ID: 37726465)
1. Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension.
Çoksevim M; Çerik İB; Yenerçağ M; Kocasarı AO; Yavuzbilge G; Polat M; Meriç M; Özgen M
Int J Cardiovasc Imaging; 2022 Oct; 38(10):2191-2197. PubMed ID: 37726465
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time.
Dogan M; Efe TH; Cimen T; Ozisler C; Felekoglu MA; Ertem AG; Erat M; Yiginer O; Tulmac M
Lung; 2018 Apr; 196(2):173-178. PubMed ID: 29445936
[TBL] [Abstract][Full Text] [Related]
3. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of the echocardiographic tricuspid annular plane systolic excursion/systolic pulmonary arterial pressure (TAPSE/sPAP) ratio and its relationship with NT-proANP plasma level in systemic sclerosis.
Grimaldi MC; Rosato E; D'Angelo A; Cristiano E; Marchitti S; Volpe M; Rubattu S; Romaniello A
Front Cardiovasc Med; 2022; 9():1021048. PubMed ID: 36733829
[TBL] [Abstract][Full Text] [Related]
5. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
6. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.
Mathai SC; Sibley CT; Forfia PR; Mudd JO; Fisher MR; Tedford RJ; Lechtzin N; Boyce D; Hummers LK; Housten T; Zaiman AL; Girgis RE; Hassoun PM
J Rheumatol; 2011 Nov; 38(11):2410-8. PubMed ID: 21965638
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic sclerosis patients.
Hekimsoy V; Kaya EB; Akdogan A; Sahiner L; Evranos B; Canpolat U; Aytemir K; Özer N; Tokgozoglu L
Int J Cardiovasc Imaging; 2018 Jun; 34(6):883-892. PubMed ID: 29322374
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
[TBL] [Abstract][Full Text] [Related]
9. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
[TBL] [Abstract][Full Text] [Related]
10. Assessment of pulmonary arterial stiffness in obstructive sleep apnea.
Ozkececi G; Ulasli SS; Akci O; Dural İE; Avsar A; Unlu M; Onrat E
Int J Cardiovasc Imaging; 2016 May; 32(5):799-805. PubMed ID: 26783146
[TBL] [Abstract][Full Text] [Related]
11. Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients.
Mukherjee M; Chung SE; Ton VK; Tedford RJ; Hummers LK; Wigley FM; Abraham TP; Shah AA
Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27266598
[TBL] [Abstract][Full Text] [Related]
12. Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis.
Xanthouli P; Miazgowski J; Benjamin N; Gordjani O; Egenlauf B; Harutyunova S; Seeger R; Marra AM; Blank N; Lorenz HM; Grünig E; Eichstaedt CA
Arthritis Res Ther; 2022 Jul; 24(1):173. PubMed ID: 35864554
[TBL] [Abstract][Full Text] [Related]
13. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
15. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
16. Echo Doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis.
Frea S; Capriolo M; Marra WG; Cannillo M; Fusaro E; Libertucci D; Morello M; Gaita F
Echocardiography; 2011 Sep; 28(8):860-9. PubMed ID: 21906161
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
18. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A; Meseguer ML; Fonollosa-Pla V; Giménez BS; Colunga-Argüelles D; Revilla-López E; Rubio-Rivas M; Ropero MJC; Argibay A; Barberá JA; Salas XP; Meñaca AM; Vuelta ABM; Padrón AL; Comet LS; Morera JAD; González-Echávarri C; Mombiela T; Ortego-Centeno N; González MM; Tolosa-Vilella C; Blanco I; Subías PE; Simeón-Aznar CP; ;
Sci Rep; 2022 Mar; 12(1):5289. PubMed ID: 35347225
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
20. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
